RXR
RXRX
stock
N/A
Accuracy
Recent Predictions
Incorrect: 0
Pending: 9
Prediction
Author
Predicted at
Status
Video
Recursion Pharmaceuticals (RXRX) is expecting results from four Phase Two clinical trials within Q1-Q2 2025.
"four of which are in phase two and expecting results within the next two quarters"
Jan 3, 2025
Pending
Recursion Pharmaceuticals (RXRX) is predicted to achieve $58 million in sales in 2025.
"driving 58 million dollar in sales this year"
Jan 3, 2025
Pending
Recursion Pharmaceuticals (RXRX) expects results from four of its Phase 2 drug pipeline trials within the first two quarters of 2025.
"four of which are in phase two and expecting results within the next two quarters"
Jan 3, 2025
Pending
Recursion Pharmaceuticals (RXRX) predicted to achieve $58 million in sales in 2025.
"driving 58 million dollar in sales this year"
Jan 3, 2025
Pending
Recursion Pharmaceuticals (RXRX) is expected to announce phase two trial results for four indications within two quarters (from the video publication date of 2024-09-04).
"the company has six programs and pipeline trials for seven indications four of which are in phase tw..."
Sep 4, 2024
Pending
Recursion Pharmaceuticals (RXRX) is expecting results for four of its Phase 2 pipeline trials within the next two quarters (Q3 and Q4 of 2024).
"four of which are in phase two and expecting results within the next two quarters"
Jun 14, 2024
Pending
Recursion Pharmaceuticals (RXRX) is expected to achieve 30% annual sales growth.
"strong intellectual property driving sales growth of 30% a year"
Jun 14, 2024
Pending
If Nvidia acquires Recursion Pharmaceuticals, its stock price could increase 10x from its then-current $9.38 (to approximately $93.80).
"if they get bought they can easily 10x from here"
Jun 12, 2024
Pending
Recursion Pharmaceuticals (RXRX) is predicted to eventually become a takeover target due to its strong balance sheet and valuable intellectual property.
"but has a strong balance sheet and some very strong intellectual property that yes could make it a t..."
Jun 3, 2024
Pending